Long Trade Setup Breakdown for (BEAM) - 30!

Long Trade Setup Breakdown for (BEAM) - 30!

? Chart

? Asset: Beam Therapeutics Inc. (BEAM)
? Timeframe: 30-Min Chart
? Setup Type: Symmetrical Triangle Breakout
? Trade Plan (Long Position):
✅ Entry Zone: $32.40 (Breakout Confirmation)
✅ Stop-Loss (SL): $29.56 (Below Support)
? Take Profit Targets (Long Trade):
? TP1: $35.64 (First Resistance)
? TP2: $39.32 (Extended Bullish Target)

? Risk-Reward Ratio Calculation:
? Risk (Stop-Loss Distance):
$32.40 - $29.56 = $2.84
? Reward to TP1:
$35.64 - $32.40 = $3.24
? Risk-Reward Ratio to TP1: 1:1.14
? Reward to TP2:
$39.32 - $32.40 = $6.92
? Risk-Reward Ratio to TP2: 1:2.43

? Technical Analysis & Strategy:
? Breakout Confirmation: Strong buying momentum above $32.40 signals continuation.
? Pattern Formation: Symmetrical Triangle Breakout, indicating bullish movement.
? Key Support & Resistance Levels:
? $29.56 (Strong Support / SL Level)
? $32.40 (Breakout Zone / Entry)
? $35.64 (First Profit Target / Resistance)
? $39.32 (Final Target for Momentum Extension)
? Momentum Shift Expected:

If price sustains above $32.40, it could push towards $35.64 and $39.32.
A high-volume breakout would confirm trend continuation.
? Trade Execution & Risk Management:
? Volume Confirmation: Ensure buying volume remains strong after breakout.
? Trailing Stop Strategy: If price reaches TP1 ($35.64), move SL to entry ($32.40) to lock in profits.
? Partial Profit Booking Strategy:
✔ Take 50% profits at $35.64, let the rest run to $39.32.
✔ Adjust Stop-Loss to Break-even ($32.40) after TP1 is hit.

⚠️ Fake Breakout Risk:
If price drops below $32.40, be cautious and watch for a retest before re-entering.
? Final Thoughts:
✔ Bullish Setup – If price holds above $32.40, higher targets are expected.
✔ Momentum Shift Possible – Watch for volume confirmation.
✔ Favorable Risk-Reward Ratio – 1:1.14 to TP1, 1:2.43 to TP2.
? Stick to the plan, manage risk, and trade smart! ??

? #StockTrading #BEAM #BreakoutTrade #TechnicalAnalysis #MarketTrends #ProfittoPath

Read More

Share:

Latest News